Literature DB >> 21763965

The role of surgery in the management of early-stage renal cancer.

Paul Russo1.   

Abstract

There were an estimated 58,240 new cases and 13,040 deaths from kidney cancer in the United States in 2010. The increased treatment and cure of small, incidentally discovered renal tumors, most of which are nonlethal in nature, has not offset the increased mortality caused by advanced and metastatic tumors. In this article, the optimum approach to the surgical management of localized renal tumors and its impact on renal function are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763965     DOI: 10.1016/j.hoc.2011.04.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

1.  PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.

Authors:  Alexander W MacFarlane; Mowafaq Jillab; Elizabeth R Plimack; Gary R Hudes; Robert G Uzzo; Samuel Litwin; Essel Dulaimi; Tahseen Al-Saleem; Kerry S Campbell
Journal:  Cancer Immunol Res       Date:  2013-11-25       Impact factor: 11.151

Review 2.  Role of embolization in the treatment of renal masses.

Authors:  David Li; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

Review 3.  Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Authors:  Dae Y Kim; Jose A Karam; Christopher G Wood
Journal:  World J Urol       Date:  2014-04-18       Impact factor: 4.226

4.  Discovering Biomarkers within the Genomic Landscape of Renal Cell Carcinoma.

Authors:  Sankin A
Journal:  J Kidney       Date:  2016-02-25

5.  Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.

Authors:  Stephen A Poon; Jonathan L Silberstein; Ling Y Chen; Behfar Ehdaie; Philip H Kim; Paul Russo
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

Review 6.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

7.  Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Authors:  Toni K Choueiri; Youjin Je; Eunyoung Cho
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

8.  End stage and chronic kidney disease: associations with renal cancer.

Authors:  Paul Russo
Journal:  Front Oncol       Date:  2012-04-02       Impact factor: 6.244

9.  Open mini-flank partial nephrectomy: an essential contemporary operation.

Authors:  Paul Russo; Roy Mano
Journal:  Korean J Urol       Date:  2014-09-05

10.  The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.

Authors:  Alexander Sankin; Abraham A Hakimi; Nina Mikkilineni; Irina Ostrovnaya; Mikhail T Silk; Yupu Liang; Roy Mano; Michael Chevinsky; Robert J Motzer; Stephen B Solomon; Emily H Cheng; Jeremy C Durack; Jonathan A Coleman; Paul Russo; James J Hsieh
Journal:  Cancer Med       Date:  2014-08-14       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.